Primary |
Breast Cancer Metastatic |
28.2% |
Premedication |
25.0% |
Breast Cancer |
22.4% |
Endometrial Cancer |
5.0% |
Prophylaxis |
2.7% |
Uterine Cancer |
2.4% |
Pain |
1.9% |
Prostate Cancer |
1.6% |
Inflammatory Carcinoma Of The Breast |
1.3% |
Non-small Cell Lung Cancer |
1.1% |
Nausea |
1.0% |
Bone Pain |
1.0% |
Hypertension |
1.0% |
Metastases To Central Nervous System |
1.0% |
Pain In Extremity |
0.9% |
Acne |
0.8% |
Anaemia |
0.8% |
Dermatitis |
0.8% |
Breast Cancer Stage Iv |
0.6% |
Anxiety |
0.5% |
|
Vomiting |
11.7% |
Death |
11.5% |
Neuropathy Peripheral |
9.8% |
No Adverse Event |
6.0% |
Fatigue |
5.7% |
Hypersensitivity |
5.2% |
Malignant Neoplasm Progression |
5.2% |
Circumstance Or Information Capable Of Leading To Medication Error |
4.9% |
Rash |
4.9% |
Neutropenia |
4.4% |
Extravasation |
3.8% |
Pain In Extremity |
3.6% |
Stomatitis |
3.6% |
Pleural Effusion |
3.3% |
Drug Administration Error |
3.0% |
Dyspnoea |
2.7% |
Myalgia |
2.7% |
Nausea |
2.7% |
Palmar-plantar Erythrodysaesthesia Syndrome |
2.7% |
Medication Error |
2.5% |
|
Secondary |
Breast Cancer |
24.6% |
Prostate Cancer |
19.5% |
Breast Cancer Metastatic |
12.3% |
Drug Use For Unknown Indication |
7.7% |
Metastases To Central Nervous System |
5.6% |
Inflammatory Carcinoma Of The Breast |
5.1% |
Autoimmune Thyroiditis |
3.6% |
Disease Progression |
3.1% |
Pain |
3.1% |
Neoplasm |
2.6% |
Premedication |
2.1% |
Endometrial Cancer |
1.5% |
Metastases To Bone |
1.5% |
Ovarian Cancer |
1.5% |
Anxiety |
1.0% |
Chemotherapy |
1.0% |
Hypertension |
1.0% |
Malignant Pleural Effusion |
1.0% |
Neuropathy Peripheral |
1.0% |
Systemic Lupus Erythematosus |
1.0% |
|
Lymphopenia |
21.3% |
Neuropathy Peripheral |
8.5% |
Pleural Effusion |
8.5% |
Neutropenia |
6.4% |
Vomiting |
6.4% |
White Blood Cell Count Decreased |
6.4% |
Atrial Fibrillation |
4.3% |
Cardiac Arrest |
4.3% |
Drug Ineffective |
4.3% |
Nausea |
4.3% |
Sepsis |
4.3% |
Thrombocytopenia |
4.3% |
Adverse Event |
2.1% |
Arthralgia |
2.1% |
Bacteraemia |
2.1% |
Cardio-respiratory Arrest |
2.1% |
Deafness Bilateral |
2.1% |
Dehydration |
2.1% |
Disease Progression |
2.1% |
Duodenal Ulcer |
2.1% |
|
Concomitant |
Breast Cancer |
24.4% |
Metastases To Lung |
14.0% |
Breast Cancer Metastatic |
12.8% |
Metastases To Bone |
9.3% |
Metastases To Liver |
9.3% |
Drug Use For Unknown Indication |
4.7% |
Arthralgia |
3.5% |
Chemotherapy |
3.5% |
Infection Prophylaxis |
3.5% |
Pain In Extremity |
3.5% |
Blood Pressure |
2.3% |
Neoplasm Malignant |
2.3% |
Bone Cancer Metastatic |
1.2% |
Convulsion Prophylaxis |
1.2% |
Depression |
1.2% |
Idiopathic Thrombocytopenic Purpura |
1.2% |
Nausea |
1.2% |
Pain |
1.2% |
|
Hepatomegaly |
10.0% |
Pyrexia |
10.0% |
Death |
6.7% |
Ejection Fraction Decreased |
6.7% |
Hypotension |
6.7% |
Pain |
6.7% |
Stomatitis |
6.7% |
Vomiting |
6.7% |
Alopecia |
3.3% |
Completed Suicide |
3.3% |
Diarrhoea |
3.3% |
Drug Ineffective |
3.3% |
Hypermetabolism |
3.3% |
Injection Site Haematoma |
3.3% |
Maculopathy |
3.3% |
Metastases To Peritoneum |
3.3% |
Osteonecrosis Of Jaw |
3.3% |
Palmar-plantar Erythrodysaesthesia Syndrome |
3.3% |
Rash |
3.3% |
Respiratory Disorder |
3.3% |
|